The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada

American Journal of Medicine

Volumn 107, Issue 4, 1999, Pages 356-362

  Walker, Alexander M ^a,b   Szneke, Priscilla ^c   Weatherby, Lisa Bianchi ^c   Dicker, Linda Webster ^a   Lanza, Lee L ^d   Loughlin, Jeanne E ^a   Yee, Chuen L ^e   Dreyer, Nancy A ^a  

^a Epidemiology Resources Inc   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Medscape   (United States)

^d Decision Resources Inc   (United States)

^e R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CISAPRIDE; IMIDAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PROKINETIC AGENT;

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; ARRHYTHMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CISAPRIDE; FEMALE; GASTROINTESTINAL AGENTS; GREAT BRITAIN; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; SASKATCHEWAN; SEX DISTRIBUTION;

EID: 0032854375     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00241-7     Document Type: Article

References (15)

1. Physician's Desk Reference. 50th ed. 1996;Medical Economics, Montvale, NJ.
2. Gerald K. McEvoy. Miscellaneous drugs. In: Gerald K. McEvoy, ed. American Hospital Formulary Service Drug Information 96. The American Society of Health-System Pharmacists Inc.; 1996; Ch.56:40.
3. Wager E., Tooley P.J.H., Pearce G.L., et al. A comparison of two cohort studies evaluating the safety of cisapride prescription-event mon-itoring and a large phase IV study . Eur J Clin Pharmacol. 52:1997;87-94.
4. Bran S., Murray W.A., Hirsch I.B., Palmer J.P. Long QT syndrome during high-dose cisapride. Arch Intern Med. 155:1995;765-768.
5. Wysowski D.K., Bacsanyi J. Cisapride and fatal arrhythmia. NEJM. 335:1996;290-291.
6. Jick H. A Major Resource for Drug Safety Studies The General Practice Research Data Base . 1994;Centre for Medicines Research, London.
7. Perry J, ed. OXMIS Problem Codes for Primary Medical Care. Oxford: 1986.
8. Jick H., Jick S.S., Derby L.E. Validation of information recorded on a general practitioner-based computerised data resource in the United Kingdom. BMJ. 302:1991;766-768.
9. Jick H., Terris B.A., Derby L.E., Jick S.S. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Safety. 1:1992;347-349.
10. De Abajo F.J., Garcia Rodriguez L.A. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. Br J Clin Pharmacol. 47:1999;307-313.
11. International Classification of Diseases. 9th revision. 1994;Medicode, Salt Lake City, Utah.
12. Canadian Classification of Diagnostic, Therapeutic, and Surgical Procedures (CCP). 1986;Statistics Canada, Health Division, Nosology Reference Centre, Minister of Supply and Services, Canada.
13. Graham A.S. Cisapride drug interactions. Adverse Drug React Alert. 8:1998;1-4.
14. Statistical Analysis System for Personal Computers. Release 6.12. 1996;SAS Institute, Inc, Cary, NC.
15. Fleiss J.L. The statistical basis of meta-analysis. Statist Meth Med Res. 2:1993;121-145.